The Pros And Cons Of Pharmaceutical Companies

The price of prescription medicines in the United States is derive from the highly-regulated FDA guidelines that are needed to guarantee medicines that are in fact safe for the consumers. I do not feel anything can be done regarding regulations that are set for patient safety. In the United States drug prices reflect a fair and competitive market. Pharmaceutical companies are in the business to provide treatment/cures to diseases that were considered killers just a few years ago. The high cost is misinterpreted as a greed endeavor. However, what the public fails to understand is that for every ten projects there is one that will provide suitable results. Those ten projects will cost billions of dollars in R&D. Not to mention that the life cycle

No matter where the patients are in the world, whether in the United States or abroad, companies should provide their patients with the drugs that they are developing. Pharmaceutical companies should hold a utilitarian view on how they operate as a business, providing the most good for the most people. While it may be difficult as a small pharmaceutical to provide drug to the patients that they are using to test said drug on, it is necessary they do. No matter the size of a pharma company it should be there obligation to treat there test subjects as ends and not as a means, as well as provide the most good for the most amount of people. Dr. Lang of CV Therapeutics should provide is patients, that were used to help develop ranolazine, with the drug after testing. This may be difficult given they are a small company however, they could make an agreement to provide the drug to them after they have grown as a company to better afford it. Dr. Lang should consider an obligation of corporate social responsibility to provide the people who willing agreed to test ranolazine with the drug its self. The consequence of not doing so can seriously affect how people view his company, and possible how they company performs over all because of

It would absolutely be unethical for companies to not sell useful drugs in poor countries simply because they could make more money in other areas. I the end the company will still profit from marketing the drug in both areas. Pharma companies should have an obligation to provide a useful drug anywhere and everywhere it is useful. If the drug is useful then it will sell, making the company money, as well as providing medicine to those who need it. An example of this is Abbott developed Kaletra to treat those with Aides. Abbott provides Africa with free product of Kaletra to treat those suffering in Africa. However, the original version was not much help since it needed to be refrigerated. Therefore, Abbott spent billions of dollars to invent an improved product that did not require the medicine to be stored in refrigeration. Although this version of Kaletra was not needed in the United States it was developed for third world countries that did not have the ability to keep Kaletra